Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-04-20
著者
-
Seki Nobuo
Pharmacology Res. Laboratories Astellas Pharma Inc. Jpn
-
Takeshita Nobuaki
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Yoshimi Eiji
Pharmacology Research Laboratories, Astellas Pharma, Inc., Japan
-
Shimizu Yasuaki
Pharmacology Research Laboratories, Astellas Pharma, Inc., Japan
-
Hatori Chie
Pharmacology Research Laboratories, Astellas Pharma, Inc., Japan
-
Kumakura Fumiyo
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Seki Nobuo
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Yoshimi Eiji
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Shimizu Yasuaki
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Hatori Chie
Pharmacology Research Laboratories Astellas Pharma Inc.
関連論文
- A NOVEL INHIBITOR OF VACUOLAR ATPase, FR202126, PREVENTS ALVEOLAR BONE DESTRUCTION IN EXPERIMENTAL PERIODONTITIS IN RATS
- Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents
- Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
- Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
- Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents